Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
Avacta Group Announces Key Affimer Patent to be Granted in China 5/24/2017
Athenex and Its Chinese Partner Announce CFDA IND Approval for KX... 5/24/2017
A Dual-Functional GLP-1 Analogue May Improve Insulin Sensitivity ... 5/16/2017
China Creates New Kinase-Based Whole-Cell Screening Library for H... 5/12/2017
PharmAust Secures Key China Patent 5/9/2017
IMPACT Therapeutics Received Chinese IND Approval for Novel PARP ... 5/4/2017
Sirnaomics Granted Chinese IND Approval for siRNA Drug for Hypert... 5/1/2017
Page:4/4    Total number of articles:97  :[1][2][3][4]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links